Long Acting Liraglutide Compositions

Abstract: The present invention relates to a composition comprising particles wherein said particles comprise Poly(lactide co glycolide) polymer therapeutically effective amount of liraglutide or a pharmaceutically acceptable salt thereof and a hydrophilic particle size modulating agent wherein the composition is free of added divalent metal ions. The composition provides effective blood glucose control for about 7 days when administered as once a week formulation to a period of about 30 days after single administration of a monthly dose to a patient in need thereof.

Patent Information

Application #

Filing Date

13 October 2016

Publication Number

36/2017

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

17/b Mahal Industrial Estate Off Mahakali Caves Road Andheri (east) Mumbai 400093

Inventors

1. KHOPADE Ajay Jaysingh

Sun Pharma Advanced Research Company Limited Nima Compound Near Pratham Enclave Tandalja Road Baroda 390020

2. HALDER Arindam

Sun Pharma Advanced Research Company Limited Nima Compound Near Pratham Enclave Tandalja Road Baroda 390020

3. PATEL Vivek

Sun Pharma Advanced Research Company Limited Nima Compound Near Pratham Enclave Tandalja Road Baroda 390020

Specification

Documents

Application Documents

#	Name	Date
1	201627035050.pdf	2018-08-11
1	Description(Complete) [13-10-2016(online)].pdf	2016-10-13
2	201627035050.pdf	2018-08-11
2	Description(Complete) [13-10-2016(online)].pdf	2016-10-13